Lista de obras -

A single-tube, sensitive multiplex method for screening of isocitrate dehydrogenase 1 (IDH1) mutations.

artículo científico publicado en 2010

AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.

artículo científico publicado en 2009

An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype.

artículo científico publicado en 2015

Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia

artículo científico publicado en 2015

Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.

artículo científico publicado en 2013

Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.

artículo científico publicado en 2013

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation.

artículo científico publicado en 2010

Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations

artículo científico publicado en 2010

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).

artículo científico publicado en 2016

Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome.

artículo científico publicado en 2018

Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia

artículo científico publicado en 2007

GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution

artículo científico publicado en 2014

GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia

artículo científico publicado en 2018

Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia

artículo científico publicado en 2017

Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients.

artículo científico publicado en 2018

IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution

artículo científico publicado en 2013

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.

artículo científico publicado en 2018

Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution

artículo científico publicado en 2006

Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia

artículo científico publicado en 2017

RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome

artículo científico publicado en 2007

SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution.

artículo científico publicado en 2014

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia

artículo científico publicado en 2016

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

artículo científico publicado en 2011

The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression

artículo científico publicado en 2014

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution

artículo científico publicado en 2012

The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model

artículo científico publicado en 2017

The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome

artículo científico publicado en 2018

Lista de obras de

A single-tube, sensitive multiplex method for screening of isocitrate dehydrogenase 1 (IDH1) mutations.

AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.

An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype.

Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia

Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.

Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation.

Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).

Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome.

Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia

GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution

GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia

Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia

Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients.

IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.

Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution

Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia

RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome

SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution.

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution

The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model

The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome